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ABSTRACT
Myeloid sarcoma (MS) is an uncommon type of malignancy, and its diagnosis is comparable to acute myeloid leu-
kaemia (AML). In the rare circumstances in which MS does present without AML, it is known as MS de novo. We 
report a case of a 10-month old child who presented with bilateral proptosis and a pelvic mass due to synchronous 
primary MS de novo. She was initially misdiagnosed with neuroblastoma, which has this typical presentation.  The 
histopathological result from the biopsy of the orbital mass also showed a small blue round cell tumour (SBRCT) as 
seen in cases of neuroblastoma. However, the diagnosis of MS was confirmed using immunohistochemistry (IHC) 
from the orbital biopsy specimen, which usually plays a major role in the diagnosis of orbital tumours and as a prog-
nostic indicator. Our patient remains in clinical remission two years after antileukemic treatment, with no relapse or 
progression to AML.
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INTRODUCTION
Bilateral proptosis is a very uncommon presentation 
in children, and it is highly indicative of a systemic 
malignancy. Once noted in a child, cancers such 
as metastatic neuroblastoma, myeloid sarcoma, 
leukaemia and lymphoma need to be ruled out urgently. 
Neuroblastoma is the most common extra-cranial 
solid tumour seen in children (1). Patients typically 
present with fever, weight loss, bilateral proptosis 
and an enlarged adrenal gland mass in the abdomen. 
Occasionally, this mass may be seen in the chest, pelvis 
or neck. Many patients also present with “racoon eyes” 
due to periorbital ecchymosis (2). 
Myeloid sarcoma (MS) is also another cause of bilateral 
proptosis. It is also known as granulocytic sarcoma 
or chloroma, owing to its green colour from the 
enzyme myeloperoxidase. It consists of extramedullary 
proliferation of blasts from the myeloid lineage. 
Therefore, the diagnosis of MS is comparable to acute 
myeloid leukaemia (AML). MS is seen in only 2-8% of 
cases of AML, with nearly half the cases of MS appearing 
after the diagnosis of AML, with another 15-35% seen 
concurrently. However, in a small number of patients, 
MS may precede AML by several months.  When MS 
presents without AML, it is known as MS de novo. 
Owing to the rarity of MS de novo, it has only been 
described in the literature in the form of case series or 
reports. We therefore describe one such case.
CASE REPORT
In August 2016, a 10-month-old girl presented to the 
ophthalmology clinic with a history of bilateral proptosis 
of seven days duration.  The mother of the child also 
reported of drooping of right eyelid and increasing 
severity of the proptosis in the left eye over the last two 
days (Figure 1).
On general inspection, the child was lethargic, and a 
bloodstained fluid oozed from her left nostril. On eye 
examination, there was no periorbital inflammation 
or ecchymosis seen. There was complete ptosis of the 
right eye, with hypoglobus and limitation in upgaze, 
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Figure 1: External photograph, pre-chemotherapy: showing bilateral 
proptosis with complete ptosis of the right eye
Figure 2:  Coronal CT scan of the obit demonstrates significant 
proptosis in the left eye due to large contrast enhancing extraconal 
masses invading the orbital apex infiltrating the posterior nasal cavity. 
In the right orbit, the extraconal mass compresses the globe inferiorly. 
Figure 3:  Sagittal CT scan of the right orbit showing an extraconal 
enhancing mass with calcification within causing compression of the 
globe inferiorly
originating from a poorly defined mass which was 
palpable in the superomedial part of the right upper lid 
extending into the orbit. The proptosis in the left eye 
was more severe and associated with restrictions in all 
direction of gaze. The pupillary reflexes in the left eye 
was impaired, and the intraocular pressure in both eyes 
was elevated at 28 mmHg. Bilateral fundus examination 
was unremarkable, with no signs of optic disc swelling 
or choroidal striae seen. On systemic examination, 
there was no lymphadenopathy, organomegaly or a 
palpable mass in the abdomen. Laboratory workups, 
which included complete blood count, peripheral 
smear, coagulation screening, renal and liver function 
tests, were within the normal reference range. The 
fungal smear and culture from the nasal cavity were also 
negative.
A contrast-enhanced computed tomography scan (CT 
scan) of the orbits was performed, which showed bilateral 
hyperdense extraconal masses with calcification within 
(Figure 2). The extraconal mass in the left orbit was larger 
than that of the right orbit; it involved the orbital apex 
and extended into the maxillary sinus and posterior nasal 
cavity. Also notable, was the fact that the extraconal 
mass in the right orbit compressed the globe inferiorly 
(Figure 3). These findings were suggestive of systemic 
metastases, leukaemia, or lymphoma. Subsequently, 
a staging CT scan was done which revealed a large, 
lobulated, heterogeneous enhancing mass in the right 
pelvis. It extended from the fifth lumbar spine to the 
pelvic floor, with no calcification or necrosis within 
(Figure 4). There was no involvement of the para-aortic 
lymph nodes, liver, spleen, or kidneys seen. A provisional 
diagnosis of neuroblastoma stage 4 was made with the 
primary tumour originating in the pelvis and causing 
metastasis to both orbits. A biopsy of the mass from the 
right upper lid was done under general anaesthesia, for 
which the histopathological results pointed to a small 
blue round cell tumour (SBRCT), which supported the 
diagnosis of neuroblastoma. Immediately, one course of 
chemotherapy was commenced to salvage the remnant 
vision in the left eye. Within one week of starting 
the chemotherapy, the bilateral proptosis reduced 
significantly, and the pupillary reflexes of the left eye 
returned to normal. 
Further staging investigation was undertaken to 
establish a treatment strategy. However, when the 
MIBG scan did not show any tracer uptake in the 
orbit, adrenal glands nor soft tissue density in the 
pelvis, this presented as a diagnostic dilemma. Other 
investigations including bone marrow trephine biopsy 
also did not show any abnormality.  After two weeks, 
the immunohistochemistry (IHC) results returned, 
which was negative for neuroblastoma but positive for 
myeloperoxidase and lysozyme biomarkers which was 
strongly indicative of MS.  Based on the IHC results, the 
Figure 4:  Axial CT scan abdomen: demonstrating a large lobulated 
heterogeneously enhancing mass pushing the urinary bladder 
anterosuperiorly
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case was re-diagnosed as synchronous MS de novo of 
the orbit and pelvis. 
The patient was subsequently treated with one cycle of 
chemotherapy for AML. The post chemotherapy CT scan 
which was conducted four months later, did not show 
any residual mass in the orbit or pelvis. She remains in 
clinical remission two years after treatment, with no 
relapse or progression to AML. Her vision also remains 
normal bilaterally.
DISCUSSION
Children with MS commonly present with skin 
manifestation (54%) followed by the orbital involvement 
(3). Ocular signs in orbital MS include acute pain, 
proptosis, and abnormal bleeding due to the tumour mass 
infiltrating the extraocular muscles and the surrounding 
structures, such as the ethmoid and maxillary sinus. 
In general, the investigations for orbital tumours include 
radiological imaging and histopathological examination 
of a biopsy specimen. The usefulness of magnetic 
resonance imaging or CT scan in the diagnosis of orbital 
MS is limited, as it is not sensitive enough to distinguish 
between this granulocytic neoplasm from other tumours. 
However, it may be indicative of MS when a contrast-
enhancing solid mass is seen on the CT scan at different 
sites or at different points in time (4).
In general, histological examination of orbital 
tumours is the only way to accurately establish the 
diagnosis of most orbital tumours. MS falls under 
the group of SBRCT, which is characterised by cells 
with a predominant nuclei and scanty cytoplasm on 
histology. Ophthalmologically-related SBRCT includes 
neuroblastoma, myeloid sarcoma, non-Hodgkin’s 
lymphoma, rhabdomyosarcoma, and Wilms’ tumour (5). 
IHC examination is essential to distinguish between the 
various SBRCT, and can diagnose MS with almost 100% 
accuracy.  However, the pathologist must have a high 
index of suspicion to run the specific biomarker panel 
for this rare malignancy. The correct diagnosis of MS 
de novo is crucial as aggressive systemic chemotherapy 
has been proven to reduce the risk of progression to 
AML, which usually occurs within the first 12 months 
of diagnosis (3). 
CONCLUSION
It is essential for clinicians to know that bilateral orbital 
lesions in children strongly suggest the presence of a 
metastatic malignant lesion, and that prompt systemic 
workup is needed to identify the primary tumour. This 
case highlights the importance of considering MS as a 
differential diagnosis of multifocal tumours involving 
the orbit. As most metastatic orbital lesions consist 
of SBRCT, IHC examination plays a crucial role, not 
only for diagnostic purposes, but also as a prognostic 
indicator and identifying the potential target for therapy. 
ACKNOWLEDGEMENT
The authors like to thank the patient and her parents for 
the kind permission in the publishing of this case report. 
REFERENCES 
1. Colon NC, Chung DH. Neuroblastoma. Adv 
Pediatr. 2011;58(1):297-311.
2. Kalaskar RR, Kalaskar AR. Neuroblastoma in 
early childhood: A rare case report and review of 
literature. Contemp Clin Dent. 2016;7(3):401-4.
3. Avni B, Koren-Michowitz M. Myeloid sarcoma: 
current approach and therapeutic options. Ther 
Adv Hematol. 2011;2(5):309-16.
4. Noh BW, Park SW, Chun JE, Kim JH, Kim HJ, 
Lim MK. Granulocytic Sarcoma in the Head and 
Neck: CT and MR Imaging Findings. Clin Exp 
Otorhinolaryngol. 2009;2(2):66-71.
5. Rajwanshi A, Srinivas R, Upasana G. Malignant 
small round cell tumors. J Cytol. 2009;26(1):1-10.
